Help develop new diagnostic tests for resource-poor countries

The PSD Study – trial of a new diagnostic test sampling and storage device for resource-poor countries

The purpose of this study is to assess a novel blood collection device, called a Plasma Separation Device (PSD), which has been developed at the Burnet Institute in Melbourne. The PSD is designed to collect and store blood samples in remote and resource-poor settings and to assist with infectious diseases testing. The study team want to measure the effectiveness of the PSD for the diagnosis of Hepatitis B, Hepatitis C and HIV. They also want to see if the PSD can detect other immune responses to infectious diseases that you have been vaccinated against (e.g. measles or tetanus).

Anticipated date that enrolment will close: April 2020

Who can take part

  • Patients presenting to VIDS outpatient clinics at Royal Melbourne Hospital, who are living with hepatitis B, hepatitis C or HIV.
  • People who can provide written informed consent
  • 18 years and over

You will be excluded if you:

  • are unable to provide your own consent.

  • have had a blood transfusion within the last 12 weeks.

What is involved for you

  • Two tubes of blood will be taken once only
check
Non-Drug
Phase 1
Phase 2
Phase 3
Phase 4

For more information

Quote reference number
2019.115
Jeni Mitchell
0402 353 888
Jack Richards
03 9342 7000